Toxicity Of Inhibitors - Cell Biology

Relevant Publications

A novel selenium analog of HDACi-based twin drug induces apoptosis and cell cycle arrest via CDC25A to improve prostate cancer therapy.

Issue Release: 2024

Cardiovascular disease burden in patients with urological cancers: The new discipline of uro-cardio-oncology.

Issue Release: 2024

Cardio-oncology in advanced prostate cancer.

Issue Release: 2024

Discovery of putative inhibitors of human Pkd1 enzyme: Molecular docking, dynamics and simulation, QSAR, and MM/GBSA.

Issue Release: 2024

In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections.

Issue Release: 2024

A reanalysis and integration of transcriptomics and proteomics datasets unveil novel drug targets for Mekong schistosomiasis.

Issue Release: 2024

Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study.

Issue Release: 2024

Diaminocyclopentane - l-Lysine Adducts: Potent and selective inhibitors of human O-GlcNAcase.

Issue Release: 2024

Design and synthesis of sulfonamide phenothiazine derivatives as novel ferroptosis inhibitors and their therapeutic effects in spinal cord injury.

Issue Release: 2024

Unveiling the promise of pyrimidine-modified CDK inhibitors in cancer treatment.

Issue Release: 2024

NAMPT Overexpression Drives Cell Growth in Polycystic Liver Disease Through Mitochondrial Metabolism Regulation.

Issue Release: 2024

Selective inhibition of c-Met signaling pathways with a bispecific DNA nanoconnector for the targeted therapy of cancer.

Issue Release: 2024

Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer.

Issue Release: 2024

HIV and adipose tissue: A long history linked to therapeutic classes of antiretrovirals.

Issue Release: 2024

Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.

Issue Release: 2024

Development of a selective novel fluorescent substrate for sodium-dependent transporters.

Issue Release: 2024

Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by F-BMS986-192 PET: pooled analysis of data from four solid tumor types.

Issue Release: 2024

Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers.

Issue Release: 2024

New Insights of Target Therapy: Effects of Tyrosine Kinase Inhibitors on Male Gonadal Function: A Systematic Review.

Issue Release: 2024

Inhibition of OSBP blocks retrograde trafficking by inducing partial Golgi degradation.

Issue Release: 2024

What Happens During Prophase?

What are Oncogenes?

Is Necrosis Treatable?

Why is Apoptosis Important?

How Does SNCA Affect Cell Biology?

What are Metabolic Disorders?

What is Confocal Microscopy?

How Does Cell Growth Occur?

How is inflammation resolved?

What is Prophase?

Partnered Content Networks

Relevant Topics